This site is intended for healthcare professionals
News

Novartis presents data at ACTRIMS-ECTRIMS for Kesimpta in newly diagnosed treatment-naïve adults with relapsing multiple sclerosis.

Read time: 2 mins
Last updated:13th Sep 2020
Published:12th Sep 2020
Condition: Multiple Sclerosis
Type: drug
Register free for full access to medthority.com